VITA C BRIGHTCREAM

Manufacturer
NOKSIBCHO cosmetic Co., Ltd.
Effective date
2020-03-14
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 23:03:57

Label at a glance#

ProductVITA C BRIGHTCREAM
Active ingredientNIACINAMIDE
Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

adenosine, vitamins, vitamin E

INACTIVE INGREDIENT SECTION

Water
Butylene glycol
Isononyl Isononanoate
Glycerin
Niacinamide
Saccharide Isomerate
Sodium Polyacrylate
Hydrogenated polydecene
Trideceth-6
Butyrospermum Parkii (Shea Butter)
Silica
Titanium Dioxide
Sorbitan Stearate(or)Sorbitan Monostearate
Orbignya Oleifera Seed Oil
PEG-40 Stearate
Arachidyl Alcohol
Behenyl Alcohol
Arachidyl Glucoside
Dipotassium Glycyrrhizate
Cetearyl Alcohol
Triethanolamine
Carbomer
Xanthan GUM
Citric Acid
Beeswax
Diisostearyl Malate
Dimethicone
Squalane
Lonicera Japonica (Honeysuckle) Flower Extract
Solanum Lycopersicum (Tomato) Fruit Extract
Lilium Tigrinum Extract
Nelumbo Nucifera Seed Extract Chrysanthemum Indicum Flower Extract
Myrciaria Dubia Fruit Extract
Euterpe Oleracea Fruit Extract
Panax Ginseng Root Extract
Aloe Barbadensis Leaf Extract
Camellia Sinensis Leaf Extract
Honey
Rosa Multiflora Fruit Extract
Gardenia Florida Fruit Extract
Scutellaria Baicalensis Root Extract
Ligustrum Japonicum Fruit Extract
Centella Asiatica Extract
Sodium Citrate
Disodium EDTA
Phaseolus Radiatus Meristem Cell Culture Extract
Camellia Sinensis Callus Culture Extract
Thymus Vulgaris (Thyme) Extract
Buddleja Davidii Extract
Tocopheryl Acetate
Ascorbic Acid
Phenoxyethanol
Ethylhexylglycerin
Parfum

OTC - PURPOSE SECTION

hyperpigmentation care

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

keep out of reach of the children

INDICATIONS & USAGE SECTION

apply proper amount and gently massage

WARNINGS SECTION

For external use only
When using this product

■ if the following symptoms occurs after use, stop use and consult with a skin specialist

red specks, swelling, itching

■ don’t use on the part where there is injury, eczema, or dermatitis

Keep out of reach of children

■ if swallowed, get medical help or contact a person control center immediately

DOSAGE & ADMINISTRATION SECTION

for external use only

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

labellabel

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-138809080826287GTIN-13: 8809080826287
EAN-13: 8809080826287
GTIN storage (14 digits): 08809080826287
label.jpg

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
73590-0015-12025-01-30C16284748780-12cef2736-adeb-d83d-e063-dadaa90ab31fDrug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
73590-0015-1VITA C BRIGHTCREAM50 mL in 1 BOTTLECREAM501

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
73590-0015VITA C BRIGHTCREAM (NIACINAMIDE) CREAM [NOKSIBCHO COSMETIC CO., LTD.]1Legacy NDC, 1 package rows20200314_a0caa16a-8e9f-7ecb-e053-2995a90afcbd.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
73590-001573590-0015-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
WATER059QF0KO0RIACT
BUTYLENE GLYCOL3XUS85K0RAIACT
NIACINAMIDE25X51I8RD4ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
a0cabb39-c306-0be1-e053-2a95a90ade71a0caa16a-8e9f-7ecb-e053-2995a90afcbd2020-03-14WarningsExact identifier
spl id: a0cabb39-c306-0be1-e053-2a95a90ade71
spl set id: a0caa16a-8e9f-7ecb-e053-2995a90afcbd

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.